Company Description
FONAR Corporation, together with its subsidiaries, engages in the designing, manufacturing, and selling magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases, abnormalities, other medical conditions, and injuries in the United States.
It operates in two segments, Medical Equipment, and Physician Management and Diagnostic Services. The company offers Upright MRI scanner, allows patients to be scanned in weight-bearing conditions, such as standing, sitting, bending, or lying down.
It also provides non-medical management, including administrative services, billing and collection services, credentialing services, contract negotiations, compliance consulting, purchasing IT services, hiring, conducting interviews, training, supervision and management of non-medical personnel, storage of medical records, office space, equipment, repair maintenance services, accounting, assistance with compliance matters, and development and implementation of practice growth and marketing strategies.
In addition, the company owns and operates diagnostic imaging facilities. The company markets its scanners to private diagnostic imaging centers and hospital outpatient imaging facilities.
FONAR Corporation was founded in 1978 and is based in Melville, New York.
| Country | United States |
| Founded | 1978 |
| IPO Date | Jan 1, 1987 |
| Industry | Diagnostics & Research |
| Sector | Healthcare |
| Employees | 520 |
| CEO | Timothy Damadian |
Contact Details
Address: 110 Marcus Drive Melville, New York 11747 United States | |
| Phone | 631-694-2929 |
| Website | fonar.com |
Stock Details
| Ticker Symbol | FONR |
| Exchange | NASDAQ |
| Fiscal Year | July - June |
| Reporting Currency | USD |
| CIK Code | 0000355019 |
| CUSIP Number | 344437405 |
| ISIN Number | US3444374058 |
| Employer ID | 11-2464137 |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Timothy R. Damadian M.D. | Chairman, President, Chief Executive Officer and Treasurer |
| Luciano B. Bonanni | Chief Operating Officer, Executive Vice President and Acting Principal Financial Officer |
| Claudette J. V. Chan | Secretary and Director |
| Daniel Culver | Director of Communications |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Nov 14, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |
| Nov 13, 2024 | SCHEDULE 13G | Filing |
| Nov 12, 2024 | 8-K | Current Report |
| Nov 12, 2024 | 10-Q | Quarterly Report |
| Sep 30, 2024 | 8-K | Current Report |
| Sep 27, 2024 | 10-K | Annual Report |
| May 21, 2024 | 8-K | Current Report |
| May 16, 2024 | 8-K | Current Report |
| May 15, 2024 | 10-Q | Quarterly Report |
| Apr 8, 2024 | DEF 14A | Other definitive proxy statements |